Literature DB >> 24495977

Loeys-Dietz syndrome: life threatening aortic dissection diagnosed on routine family screening.

Claire A Martin1, Virginia E Clowes, John P Cooper.   

Abstract

A 52-year-old man was found to have a severely dilated aortic root and a Stanford type A dissection on familial screening echocardiography, following diagnosis of a dilated aorta in his son. The dissection required urgent surgical repair. Clinical examination suggested features of Loeys-Dietz syndrome type II, and subsequent demonstration of a mutation in the TGFBR1 gene in the patient and his son confirmed the diagnosis. This article highlights the high prevalence of inherited conditions in dilated aortic root presentations and the importance of family screening and surveillance to allow early surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24495977      PMCID: PMC3918618          DOI: 10.1136/bcr-2013-203063

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Authors:  M Pepin; U Schwarze; A Superti-Furga; P H Byers
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

2.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 3.  Making sense of latent TGFbeta activation.

Authors:  Justin P Annes; John S Munger; Daniel B Rifkin
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

4.  Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.

Authors:  Ronald V Lacro; Lin T Guey; Harry C Dietz; Gail D Pearson; Anji T Yetman; Bruce D Gelb; Bart L Loeys; D Woodrow Benson; Timothy J Bradley; Julie De Backer; Geoffrey A Forbus; Gloria L Klein; Wyman W Lai; Jami C Levine; Mark B Lewin; Larry W Markham; Stephen M Paridon; Mary Ella Pierpont; Elizabeth Radojewski; Elif Seda Selamet Tierney; Angela M Sharkey; Stephanie Burns Wechsler; Lynn Mahony
Journal:  Am Heart J       Date:  2013-03-26       Impact factor: 4.749

5.  The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience.

Authors:  Gustavo S Oderich; Jean M Panneton; Thomas C Bower; Noralane M Lindor; Kenneth J Cherry; Audra A Noel; Manju Kalra; Timothy Sullivan; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2005-07       Impact factor: 4.268

6.  Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.

Authors:  B L Loeys; E E Gerber; D Riegert-Johnson; S Iqbal; P Whiteman; V McConnell; C R Chillakuri; D Macaya; P J Coucke; A De Paepe; D P Judge; F Wigley; E C Davis; H J Mardon; P Handford; D R Keene; L Y Sakai; H C Dietz
Journal:  Sci Transl Med       Date:  2010-03-17       Impact factor: 17.956

7.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

8.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

Authors:  Enid R Neptune; Pamela A Frischmeyer; Dan E Arking; Loretha Myers; Tracie E Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y Sakai; Harry C Dietz
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

Review 9.  New insights into TGF-beta-Smad signalling.

Authors:  Peter ten Dijke; Caroline S Hill
Journal:  Trends Biochem Sci       Date:  2004-05       Impact factor: 13.807

10.  Life expectancy in the Marfan syndrome.

Authors:  D I Silverman; K J Burton; J Gray; M S Bosner; N T Kouchoukos; M J Roman; M Boxer; R B Devereux; P Tsipouras
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.